Previous close | 79.75 |
Open | 80.47 |
Bid | 79.97 x 800 |
Ask | 80.01 x 800 |
Day's range | 79.74 - 81.00 |
52-week range | 76.77 - 105.99 |
Volume | |
Avg. volume | 3,101,413 |
Market cap | 47.657B |
Beta (5Y monthly) | 1.42 |
PE ratio (TTM) | 16.78 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.06 (2.58%) |
Ex-dividend date | 12 May 2022 |
1y target est | N/A |
ST. LOUIS, June 30, 2022--Emerson (NYSE: EMR) today announced it has acquired Fluxa, a leader in the life sciences industry that uses software and modern technology architectures to accelerate the speed to market for new therapies, drugs and vaccines. The acquisition builds on Emerson’s leading software and solutions portfolio and life sciences expertise. Emerson made an equity investment in Fluxa, which is based in Glendale, California, in 2021.
RÉUNION ISLAND, June 28, 2022--Global technology and software company Emerson (NYSE: EMR) has been selected by Albioma (PAR: ABIO), a French independent energy provider, to help transition its coal-fired Bois Rouge plant to 100% renewable energy. As part of Albioma’s wider mission to transition all of its existing fossil fuel plants to renewable energy, Emerson’s automation systems and software will enable the coal-fired power station to convert to biomass feedstock.
PIRKKALA, Finland, June 21, 2022--Fintoil, together with Neste Engineering Solutions, has selected Emerson’s (NYSE: EMR) automation software and technologies to maximize the operational performance of its biorefinery being constructed in the port of Hamina-Kotka, Finland. The plant will be the third-largest crude tall oil (CTO) biorefinery in the world and produce advanced biofuel and biochemical feedstocks that help lower emissions and reduce reliance on fossil-based fuels.